Teachers Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $11.9M | Buy |
127,013
+8,967
| +8% | +$838K | 0.01% | 907 |
|
2018
Q4 | $8.61M | Buy |
118,046
+6,593
| +6% | +$481K | 0.01% | 1005 |
|
2018
Q3 | $9.75M | Buy |
111,453
+151
| +0.1% | +$13.2K | 0.01% | 1086 |
|
2018
Q2 | $11M | Buy |
111,302
+3,812
| +4% | +$375K | 0.01% | 1041 |
|
2018
Q1 | $12.8M | Buy |
107,490
+4,709
| +5% | +$561K | 0.02% | 927 |
|
2017
Q4 | $13.1M | Buy |
102,781
+7,911
| +8% | +$1.01M | 0.02% | 935 |
|
2017
Q3 | $11.1M | Buy |
94,870
+10,191
| +12% | +$1.2M | 0.02% | 982 |
|
2017
Q2 | $6.75M | Buy |
84,679
+4,441
| +6% | +$354K | 0.01% | 1181 |
|
2017
Q1 | $4.11M | Buy |
80,238
+6,662
| +9% | +$341K | 0.01% | 1397 |
|
2016
Q4 | $2.76M | Buy |
73,576
+7,048
| +11% | +$264K | ﹤0.01% | 1600 |
|
2016
Q3 | $4.51M | Buy |
66,528
+3,114
| +5% | +$211K | 0.01% | 1258 |
|
2016
Q2 | $3.52M | Buy |
63,414
+3,897
| +7% | +$216K | 0.01% | 1340 |
|
2016
Q1 | $3.74M | Sell |
59,517
-52,120
| -47% | -$3.27M | 0.01% | 1256 |
|
2015
Q4 | $10.5M | Sell |
111,637
-52,991
| -32% | -$4.99M | 0.02% | 852 |
|
2015
Q3 | $13.2M | Buy |
164,628
+4,487
| +3% | +$361K | 0.03% | 717 |
|
2015
Q2 | $19.2M | Buy |
160,141
+62,948
| +65% | +$7.55M | 0.04% | 574 |
|
2015
Q1 | $10.1M | Buy |
97,193
+50,490
| +108% | +$5.27M | 0.02% | 884 |
|
2014
Q4 | $4.53M | Sell |
46,703
-50,612
| -52% | -$4.91M | 0.01% | 1180 |
|
2014
Q3 | $7.6M | Sell |
97,315
-676
| -0.7% | -$52.8K | 0.02% | 990 |
|
2014
Q2 | $6.19M | Sell |
97,991
-41,114
| -30% | -$2.6M | 0.01% | 1059 |
|
2014
Q1 | $9.34M | Buy |
139,105
+55,870
| +67% | +$3.75M | 0.02% | 839 |
|
2013
Q4 | $5.36M | Buy |
83,235
+2,671
| +3% | +$172K | 0.01% | 1061 |
|
2013
Q3 | $5.16M | Buy |
80,564
+3,732
| +5% | +$239K | 0.01% | 1020 |
|
2013
Q2 | $2.38M | Buy |
+76,832
| New | +$2.38M | 0.01% | 1325 |
|